← HB3057 bill details

Substantive final action

HB3057

Read 3rd time RV#2043

Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.

Passed House May 10, 2025⭐ Substantive final action

109Yea
22Nay
3Not voting
16Absent

Yea (109)

Nay (22)

Not Voting (3)

Absent (16)

Source provenance